Biotechnology major Biocon on Thursday reported a 6.62 per cent fall in consolidated net profit at Rs 202.8 crore for the quarter ended December 31, 2019 on account of higher expenses.
The company had posted a net profit of Rs 217.2 crore for the corresponding period of the previous fiscal, Biocon said in a filing to the BSE.
However, the company's revenue from operations rose to Rs 1,748.1 crore for the quarter under consideration as against Rs 1,540.8 crore during the same period a year ago.
Expenses rose to Rs 1,465.6 crore for December quarter as against Rs 1,295.4 crore in the year-ago period.
Shares of Biocon Ltd on Thursday closed at Rs 294.20 per scrip on the BSE, up 0.50 per cent from previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app